Bivalirudin: role in current percutaneous coronary intervention practice

被引:1
|
作者
West, N [1 ]
机构
[1] Gloucestershire Hosp NHS Fdn Trust, Gloucester GL1 3NN, England
[2] John Radcliffe Hosp, Oxford OX3 9DU, England
关键词
D O I
10.12968/hmed.2005.66.12.20208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bivalirudin is the only thrombin-specific anticoagulant currently licensed in the UK for use as an anticoagulant during percutaneous coronary intervention. This review examines the rationale for, and data supporting, its use in contemporary percutaneous coronary intervention practice.
引用
收藏
页码:687 / 689
页数:3
相关论文
共 50 条
  • [1] Bivalirudin in percutaneous coronary intervention: The EUROpean BiValIrudin UtiliSatION in Practice (EUROVISION) Registry
    Hamon, Martial
    Nienaber, Christopher A.
    Galli, Stefano
    Huber, Kurt
    Lipiecki, Janusz
    Hill, JonathanM.
    Amabile, Nicolas
    Bernstein, Debra
    Deliargyris, Efthymios
    Lafont, Antoine
    Steg, Philippe Gabriel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (02) : 290 - 294
  • [2] Bivalirudin in percutaneous coronary intervention
    Caron, MF
    McKendall, GR
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (18) : 1841 - 1849
  • [3] Bivalirudin in percutaneous coronary intervention
    Lehman, Sam J.
    Chew, Derek P.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (04) : 357 - 363
  • [4] Efficacy and Safety of Bivalirudin in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention in Current Clinical Practice
    Kim, Luke K.
    Wong, S. Chiu
    Minutello, Robert M.
    Bergman, Geoffrey
    Feldman, Dmitriy N.
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (03): : 94 - 100
  • [5] Is there a role for BivaliRUdin in Transradial Percutaneous Coronary Intervention? - The BRUT PCI Study
    Adusumalli, Sundeep
    Harris, Gregory
    Chagarlamudi, Arjun
    Nash, Gary M.
    Siddiqui, Adeel
    Paladugu, Nikhil
    Daggubati, Ramesh B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B97 - B97
  • [6] Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes
    Bates E.R.
    Current Cardiology Reports, 2001, 3 (5) : 348 - 354
  • [7] Bivalirudin in Percutaneous Coronary Intervention, is it the Anticoagulant of Choice?
    Mahmoud, Ahmed
    Saad, Marwan
    Elgendy, Akram Y.
    Abuzaid, Ahmed
    Elgendy, Islam Y.
    CARDIOVASCULAR THERAPEUTICS, 2015, 33 (04) : 227 - 235
  • [8] Bivalirudin during percutaneous coronary intervention in acute coronary syndromes
    Laine, Marc
    Lemesle, Gilles
    Dabry, Thibaut
    Panagides, Vassili
    Peyrol, Michael
    Paganelli, Franck
    Bonello, Laurent
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (03) : 295 - 304
  • [9] Bivalirudin in acute coronary syndrome's and percutaneous coronary intervention
    Lee, Michael S.
    Makkar, Rajendra R.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2006, 7 : S27 - S34
  • [10] Improving outcomes with bivalirudin in primary percutaneous coronary intervention
    Stone, Gregg W.
    EUROPEAN HEART JOURNAL, 2014, 35 (34) : 2269 - 2272